Industry – Page 20 – Swanson Reed | Specialist R&D Tax Advisors

APEX Biologix is set to participate in the third cohort of Mayo Clinic and ASU’s MedTech Accelerator program

The Mayo Clinic and ASU MedTech Accelerator, a flagship program of the Mayo Clinic and ASU Alliance for Health Care, launched their third cohort on March 28, 2022. Utah’s APEX Biologix, has been selected as one of the eight participants.

The accelerator provides emerging companies with a multi-day immersive curriculum in health care entrepreneurship including: lectures and workshops with world-class scientific and engineering experts; resources to navigate regulatory pathways; and tools for product commercialization and customer acquisition. Additionally, participants attend mentoring, business development, and networking events.

APEX Biologix, an emerging industry leader in orthobiologics, continuously strives to develop innovative regenerative medicine equipment and supplies for their customers. With FDA-registered Class II PRP kits of all kinds, the company has improved platelet count capabilities, reducing processing time and the risk of human error.

Working with the MedTech Accelerator, the company intends to continue this endeavor, developing and supplying physicians with the best products and education available to treat their patients and improve the quality of their lives.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Polaris Sensor Technologies Granted Funding from Innovate Alabama

Kentucky Patent of the Month - November 2021

Polaris Sensor Technologies, Inc. is one of 19 small businesses in Alabama to be awarded a grant from the second round of Innovate Alabama’s Supplemental Grant Program. The program distributed more than $3 million in grants across all 19 companies.

Polaris Sensor Technologies was awarded their grant for their work developing facial recognition systems for long range, covert, nighttime operations. This project specializes in designing, fabricating and testing optical systems and sensors. The supplemental funding will be used to deliver SkyPASS to markets.

Going on two decades in business, the company is a leading electro-optic sensor company focused on developing advanced optical systems for nearly any application.

SkyPASS – or Sky Polarization Azimuth Sensing System, provides mission-critical, highly-accurate attitude information regardless of GPS accessibility. The technology powers the system using a low-power, low-cost, and tiny form factor while finding North with less than 2-mil accuracy.

The funds are meant to help these local business owners grow roots in Alabama by supporting the development of modern technology. The initiative will continue to enhance Alabama’s competitiveness on a regional and national scale through increased research and commercialization efforts, the creation of exportable products and services and the development of high-wage job opportunities.

The other 18 companies include:

Adjuvax specializes in vaccine adjuvant discovery and development. The supplemental funding will be used to develop a new adjuvant formulation for various vaccines against infectious diseases.
Analytical AI specializes in artificial intelligence. The supplemental funding from Innovate Alabama will be used to supplement funds for hiring developers and purchasing development hardware for work based in Alabama.
Arcarithm specializes in artificial intelligence and command and control applications. Supplemental funding will be used to implement machine learning algorithms, increase compatibility and develop a marketing plan.
Avilution specializes in the development of modular open systems avionics software microservices supporting the civilian and defense aerospace industries.
AVNIK Defense Solutions specializes in research and development, logistics engineering, predictive analytics, and usage-based maintenance. The supplemental funding will be used to address the integration of unmanned aircraft systems into the National Airspace System.
Botts Innovative Research specializes in the design and application of Open Geospatial Consortium Sensor Web Enablement standards for sensor systems within the intelligence, defense, commercial and scientific communities.
Cleaned and Green specializes in the conversion of poultry litter into fertilizer. The supplemental funding will construct a pilot testing plant at Auburn University.
GasTOPS specializes in oil debris analysis products, solutions, and services. The supplemental funding will be used to progress the design and fielding of an oil debris monitoring system for the F100 engine on the Air Force’s F-16s. The oil debris monitoring system has the capability to increase readiness and safety while reducing operating costs.
GeneCapture is developing portable diagnostic instruments to rapidly identify infections and determine appropriate antibiotics. The supplemental funding will help add animal pathogens to the panel.
The MRIMath physician-in-the-loop AI-driven platform empowers physicians to more accurately and efficiently delineate tumor borders and map organs at risk for radiation therapy planning.
NeXolve specializes in aerospace products for NASA, DoD and commercial markets. The supplemental funding will be used to develop a commercial drag sail product to minimize space debris.
ReLogic Research has core competencies in advanced materials and advanced manufacturing applications, including automated and adaptive manufacturing processes.
RippleWorx specializes in customizable performance accelerator Software as a Service platform for high performing organizations and teams. The supplemental funding will be used to further develop a disaster triage solution for responders.
SemanticGuard specializes in defending organizations against cyber threats by guarding legacy and emerging software applications during development and operations.
SSS Optical Technology specializes in polymer nanocomposite coatings for solar cells imbedded in NASA solar sails. The supplemental funding will be used to maturate and patent the technology.
Sync specializes in proactively identifying high-risk vegetation. The supplemental funding will be used to improve our product and integrate it with a resource mobilization platform.
Tango Tango specializes in enhancing first responder voice communications. The supplemental funding will be used to add new interoperability capabilities between first responder agencies.
Tricorder Array Technologies is developing the PenPal – a wireless device that collects environmental and mouse squeaks in research cages to understand the behavior and environment influence on animal studies.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

KULR Technology Group Brings R&D to Texas

KULR Technology Group Inc., a disruptive thermal management technology company, has opened a new R&D center in Webster, Texas.

The company is focused on developing technologies to fulfill the unmet needs in the thermal management systems market. Their integrated design incorporates thermal interface materials, lightweight heat exchangers, and protection against lithium-ion battery thermal runaway propagation.

The new facility will help the company accommodate their increasing battery development engagements in 2023 and beyond. In fact, the company’s CTO Dr. Will Walker believes the new center will usher in the next phase of KULR’s expansion and growth.

The company said its sales, marketing, project management, quality control, and customer care divisions would continue to be headquartered in San Diego, California, however, the Webster facility’s design could accommodate future expansion as KULR continues to invest in people and assets in Texas.

The company expects the Webster facility to be fully operational by April 2023.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Gene MassID Wins $2K at University of Arkansas’ Funding Pitch Competition

Louisiana Patent of the Month - August 2021

Gene MassID, a student team competing in the fall seed Funding Pitch Competition organized by the University of Arkansas’ Office of Entrepreneurship and Innovation, has secured $2,000 for legal fees and further research.

This team is focused on improving treatment for brain cancer through DNA analysis by developing a diagnostic tool that uses personalized medicine to treat glioblastoma multiforme. This is an aggressive form of cancer with a 95% mortality rate.

The startup believes their tool will help to get rid of guesswork in brain cancer treatment, giving patients another chance at life.

Gene MassID was among 10 teams to receive funding in the Oct. 11 competition, which awarded more than $10,000. The competition was held in tandem with OEI’s inaugural SEED Arkansas Summit and hosted at the David and Barbara Pryor Center for Arkansas Oral and Visual History in downtown Fayetteville.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Plus Therapeutics Awarded $17.6 Million from State of Texas

Plus Therapeutics, Inc. has recently announced it has been awarded a $17.6 million Product Development Research grant by the Cancer Prevention and Research Institute of Texas (CPRIT). This grant will help fund the continued development of their lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome (186RNL), for the treatment of patients with leptomeningeal metastases (LM).

This clinical-stage pharmaceutical company has focused their expertise on developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers. LM is one of the most devastating and aggressive late-stage cancer complications. It’s this complication that characterizes the primary cancer spreading to the central nervous system. With promising results from Plus Therapeutics, the FDA has granted Fast Track designation to 186RNL for the treatment of LM.

“The Plus team is honored to receive this significant and esteemed award from CPRIT,” said Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics. “We expect that the non-dilutive funding from CPRIT will come on-line next month once the award agreement is finalized and this will significantly offset our longer-term, three-year capital requirements for the advancement of our LM program.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Sesame Solar, Inc. Powers their Mobile Disaster Relief Units with Clean Energy

Michigan-based startup Sesame Solar has been making news the past few months as they announced the release of their mobile disaster relief units and their nanogrids. These nanogrids allow the company to leverage solar power and green hydrogen as a source of reliable and renewable energy. Their disaster relief units take advantage of this capability, ensuring relief comes from clean energy.

The relief units can be used for mobile communications and command centers, medical units, kitchens, and even temporary housing. They can be ready for use within 15 minutes of arrival.

Until now, other mobile disaster relief units have been powered by diesel fuel which contributes to climate change. Sesame’s solar paneled units overcome this limitation. They also inspire the company’s name. The folded solar panels unfold, opening up to collect energy from the sun – a reference to “open sesame”.

Beyond solar power, the unit is designed with two backup power sources. Between batteries and geen hydrogen there is no limitation in clean energy sources. The company has even worked to achieve wind turbines, though this option is limited by conditions.

“The whole concept is that no fossil fuels are required to be able to have days or weeks of energy autonomy after an extreme weather disaster, like a hurricane or tornado or wildfire, or an event of grid outage in California…or a cyber-attack, or anytime the grid is just down,” said Sesame co-founder and CEO Lauren Flanagan.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

ARS Pharmaceuticals and Silverback Therapeutics Set to Merge into a Single Entity Focused on EpiPen Alternative

ARS Pharmaceuticals has announced a merger with Silverback Therapeutics. Going forward, the combined company will be called ARS Pharmaceuticals.

The newly combined company will focus their expertise on regulatory approval and commercialization of ARS’s epinephrine nasal spray for severe allergic reactions. The spray, called neffy, is a potential easy-to-use alternative to the EpiPen.

The combined company is expected to have $265 million in cash, cash equivalents and marketable securities upon closing, including $240 million in cash from Silverback. Silverback equity holders will own about 37% of the new company, and ARS’s 63%. The deal is expected to close in the fourth quarter of this year, pending stockholder approval.

Silverback made a name for themselves for their experimental solid tumor therapy following a public offering in late 2020. ARS, which raised $55 million in a Series D round of funding last spring, plans to submit its NDA (new drug application) for neffy to the U.S. Food and Drug Administration by the third quarter of this year. If the spray is approved, the company aims to launch the product in 2023.

The design of this EpiPen alternative would remove the need for needles, making administration less painful in a moment of panic. Less pain means less hesitation means less lives lost.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Cleerly Brought $192M in Series C Funding

Cleerly, Inc., a New York-based startup, has announced a successful Series C funding which brought in $192 million, effectively quadrupling their previous funding.

The company is developing artificial intelligence capable of predicting heart attacks. The investment came after the company proved their noninvasive solution is on par with the current gold standard of coronary angiography in spotting signs of heart disease. The funding will help Cleerly in their efforts to bring the technology global.

Cleerly intends to direct the money towards building out their team, expanding the commercial reach of their software, and supporting more than a dozen ongoing clinical trials to further back up the technology’s claims.

The Series C funding round was led by T. Rowe Price Associates, T. Rowe Price Investment Management and Fidelity Management and Research Company. This large infusion follows shortly after a Series B funding round announced in June, which brought in $43 million.

The software analyzes noninvasive CT angiography scans of the heart to both characterize and measure the amount of plaque built up in the arteries. By evaluating the likelihood that those build-ups could completely cut off the supply of oxygen to a patient’s heart, the software is able to identify early signs of heart disease and calculate the risk that a patient will experience a heart attack.

The system is powered by a database of millions of previously assessed CT images, as well as data collected in clinical trials spanning thousands of patients. Cleerly is aiming to further expand that repository with its ongoing studies, which plan to enroll more than 100,000 patients from across the globe within the next decade.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

BEMY Cosmetics Selected for MassChallenge’s 2022 Cohort

BEMY Cosmetics is one of 7 Houston startups chosen for MassChallenge’s 2022 United States cohort of early-stage startups. MassChallenge is the global network for innovators who are working to solve massive challenges.

As a selected startup, BEMY will be eligible for equity-free cash prizes of as much as $1 million. The company will also have access to MassChallenge’s new residency program, allowing the founder teams to travel between the various MassChallenge hubs.

BEMY set out to revolutionize the cosmetic industry through the advancement of rejuvenating adult human cells for mass market-oriented and personalized products. The idea came about when the founders decided to combine proven RNA technology with personalized skin cream. Between expertise and a novel idea, BEMY quickly became the first and only company in the world to use RNA reprogramming technologies for rejuvenating adult human skin cells.

This has been no easy task, requiring years of experimentation and engineering to develop this solution. From prototypes to patents, the startup has overcome extensive uncertainties. Their technology reprograms adult human skin cells, returning them to a near embryonic elasticity, ensuring the results have all the benefits and none of the ethical risk of embryonic stem cell technologies. The process requires the collection of your own skin cells, from a small and gentle scrape along your skin, before developing a personalized extract capable of rejuvenating your skin.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Pearlita Foods Unveils Plant-Based Oyster Prototype

While oysters are a delicious treat to many, the practice of oyster farming packs some serious environmental implications. Oyster farming is known to result in a net removal of nutrients from the water column causing a domino effect of environmental damage. Pearlita Foods looked at these impacts and decided there must be a better way.

So they developed the world’s first plant-based oyster prototype which looks and tastes exactly like a traditional oyster.

This cell-cultured seafood startup engaged in a truly extensive process of experimentation to get the right textures and authentic ocean tastes. The result is a prototype made using plant-based and cell-based technologies with a proprietary mushroom and seaweed base. Combining this with Pearlita’s novel flavor mixture is the key to achieving the pure oyster taste.

Their next steps will focus on creating a biodegradable oyster shell to achieve the same experience that comes with traditional oysters. Ofcourse, there would be no need to shuck, making it easier to serve and eat.

The best part? Plant-based oysters offer a solution to meet the global demand without the impact on the ocean. In addition to the plant-based solution, they have been working with a cell-based solution. This alternative can produce fully cultured oysters using an oyster tissue sample. Cells from a sample can be used to produce thousands of cultivated oysters.

While the startup continues its research and development on cultured oysters and biodegradable shells, Pearlita will debut its hybrid plant-based oyster using recycled oyster shells for its showcasing and tastings. In North Carolina, where Pearlita is headquartered, many coastal communities offer shell recycling drop-off locations to build new oyster reefs instead of disposing of the shells in landfills.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.